Guardant Health

IPO

Conquering Cancer With Data

Public · Palo Alto, United States · Founded 2012 · $550.0M raised

Employees
1001–5000
Founded
2012
Business Model
B2B
Total Funding
$550.0M
Last Round
$360.0M Series EMay 2017
Rounds
5
Type
Public

About

Guardant Health is a leading precision oncology company that uses liquid biopsy technology to transform cancer care. Its blood tests—including the Shield screening test and Guardant360 oncology portfolio—enable early cancer detection and guide treatment decisions for over 12,000 physicians. The company combines advanced genomics with real-world data and AI analytics to accelerate drug development for biopharma partners.

Summary

Guardant Health is a Biotech company based in Palo Alto, United States, founded in 2012. It has raised $550.0M in total across 5 rounds, most recently a $360.0M Series E round in May 2017. Investors include Sequoia Capital, SoftBank and Lightspeed VP.

Tech & App Stack

24 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Secondary MarketPost-IPO EquityNov 2025
$350.0M

Sign up to see all 8 rounds

Series A through Secondary Market — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Guardant Health on Indexed.vc
<a href="https://indexed.vc/companies/guardant-health"><img src="https://indexed.vc/api/badge/company/guardant-health" alt="Guardant Health on Indexed.vc" width="260" height="76" /></a>